Persistent Systems shares slide 5% regardless of Q2 earnings progress. Buy, promote or maintain?
Consolidated earnings rose 7.8% quarter-on-quarter in fixed forex to $487.6 million, beating market expectations. EBIT margin, nevertheless, contracted 100 foundation factors QoQ to fifteen%, lacking estimates. Profit after tax fell 27.2% QoQ to Rs 351.51 crore, impacted by increased amortisation prices from massive deal execution and one-time acquisition bills.
Overall whole contract worth stood delicate at $633.5 million, with administration noting that macro-related uncertainty delayed consumer decision-making within the quarter’s last weeks.
“We are happy to report Q2 FY27 earnings of USD 487.6M, marking our twenty sixth sequential quarter of progress. This displays a 7.8% enhance quarter over quarter and 20.0% 12 months over 12 months, with an EBIT margin of 15.0%,” mentioned Sandeep Kalra, Chief Executive Officer and Executive Director.
Q2 earnings sturdy, margins underneath strain
The margin weak spot was pushed by a mix of wage hikes, decrease utilisation and amortisation linked to a big buyer deal, in response to Nomura. These pressures have been partly offset by decrease promoting, normal and administrative bills and beneficial forex actions.
Nomura mentioned the quarter was a “combined bag”, with earnings broadly in line however a big margin miss. It retained a Neutral ranking on the inventory whereas elevating its goal value to Rs 5,600 from Rs 5,330, citing wealthy valuations. The brokerage expects margin restoration over the following few quarters as massive deal amortisation eases and prices are optimised.
Deal momentum was one other weak spot. Persistent reported whole contract worth of $633.5 million and annual contract worth of $481 million for the quarter. Nomura famous that deal wins softened after an distinctive first quarter, with administration attributing among the slowdown to delayed consumer decision-making amid the macro atmosphere.
Buy, promote or maintain Persistent Systems shares?
JPMorgan retained an Overweight ranking with a Rs 6,400 goal, highlighting the 7.8% fixed forex sequential earnings progress, pushed by massive tech deal ramp-up and a vendor consolidation win at a big BFSI consumer. However, it expects margin strain from amortisation prices linked to the massive expertise deal.
CLSA additionally retained its High Conviction Outperform name with a Rs 6,488 goal. It famous that earnings was 2% forward of consensus, though EBIT and adjusted PAT have been beneath expectations. The brokerage expects earnings, EBIT and EPS compound annual progress charges of 16%, 19% and 22%, respectively, over FY27-29.
Nuvama, in the meantime, retained its Hold ranking and lower its goal value to Rs 5,450 from Rs 5,500. It mentioned Persistent continues to ship industry-leading progress, however the inventory’s 34x FY28E PE valuation, coupled with incremental dangers from the Nagarro acquisition, makes the risk-reward unattractive.
The Nagarro deal stays a key a part of the asset placement story. Persistent has secured roughly 94.04% of Nagarro’s share capital and voting rights and is progressing in direction of the takeover, whereas administration expects the acquisition to strengthen engineering capabilities, geographic diversification and international supply.
Disclaimer: This article has been written by Sakshi Kumari, who will not be a SEBI-registered Research Analyst or an Investment Adviser. Sakshi Kumari and her ‘relative(s)’ (as outlined underneath Section 2(77) of the Companies Act, 2013) don’t maintain any monetary curiosity within the firms talked about on this article as of the date of publication. The views/suggestions talked about on this article, wherever relevant, are these of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They shouldn’t be construed because the views or suggestions of The Economic Times Digital or the journalist. Readers are suggested to contemplate the unique analysis report and make their asset placement choices based mostly on their very own evaluation. Brokerage disclaimers here
